Neurocarrus
Paul Blum is the CEO and co-founder of Neurocarrus, a startup that is developing technology to help researchers study the brain. Paul was previously a professor at the University of Nebraska.
Paul Blum has a postdoctoral degree from Stanford University School of Medicine and a postdoctoral degree from University of California, Berkeley. Paul also has a Doctor of Philosophy in Microbiology from University of California, Davis.
This person is not in any offices
Neurocarrus
Neurocarrus is a biotechnology company developing a novel drug delivery technology to safely disrupt pain signals without addiction-forming medications or disruption of muscular control. Their first-in-class therapeutic (N-001) is designed to treat the physiological symptoms of pain without invasive surgical procedures or systemically absorbed drugs.